Olanzapine attenuates the okadaic acid-induced spatial memory impairment and hippocampal cell death in rats

Neuropsychopharmacology

Volumn 30, Issue 8, 2005, Pages 1511-1520

  He, Jue ^a   Yang, Yi ^b   Xu, Haiyun ^a   Zhang, Xia ^a   Li, Xin Min ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b JILIN UNIVERSITY   (China)

Author keywords

Cell death; Hippocampus; Memory; Neuroprotection; Okadaic acid; Olanzapine

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE; OKADAIC ACID; OLANZAPINE; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CELL DEATH; CONTROLLED STUDY; DRUG EFFECT; FOOD INTAKE; HIPPOCAMPUS; LOCOMOTION; MALE; MAZE TEST; MEMORY DISORDER; NICK END LABELING; NISSL STAINING; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SPATIAL MEMORY; TASK PERFORMANCE;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BENZODIAZEPINES; CELL COUNT; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HIPPOCAMPUS; IN SITU NICK-END LABELING; MALE; MAZE LEARNING; MEMORY DISORDERS; MICROINJECTIONS; MOTOR ACTIVITY; OKADAIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS; SPATIAL BEHAVIOR; STATISTICS;

EID: 23844547937     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300757     Document Type: Article

References (61)

1. Alvarado MC, Bachevalier J (2005). Selective neurotoxic damage to the hippocampal formation impairs performance of the transverse patterning and location memory tasks in rhesus macaques. Hippocampus 15: 118-131.
2. Arendt T, Holzer M, Fruth R, Bruckner MK, Gartner U (1995). Paired helical filament-like phosphorylation of tau, deposition of β/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A. Neuroscience 69: 691-698.
3. Arendt T, Holzer M, Fruth R, Bruckner MK, Gartner U (1998). Phosphorylation of tau, Aβ-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A. Neurobiol Aging 19: 3-13.
4. Arias C, Becerra-Garcia F, Arrieta I, Tapia R (1998). The protein phosphatase inhibitor okadaic acid induces heat shock protein expression and neurodegeneration in rat hippocampus in vivo. Exp Neurol 153: 242-254.
5. Arias C, Sharma N, Davies P, Shafit-Zagardo B (1993). Okadaic acid induced early changes in microtubule-associated protein 2 and tau phosphorylation prior to neurodegeneration in cultured cortical neurons. J Neurochem 61: 673-682.
6. Arnold SE, Trojanowski JQ (1996). Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol 92: 217-231.
7. Bai O, Chlan-Fourney J, Bowen R, Keegan D, Li XM (2003). Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J Neurosci Res 71: 127-131.
8. Bai O, Zhang H, Li XM (2004). Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus. Brain Res 1010: 81-86.
9. Beasley CM, Sanger T, Satterlee W, Tollefson GD, Tran PV, Hamilton S (1996). Olanzapine vs. placebo: results of a double-blind, fixed-dose olanzapine trial. Psychopharmacology 124: 159-167.
10. Beasley CM, Tollefson GD, Tran PV (1997). Efficacy of olanzapine: an overview of pivotal clinical trials. J Clin Psychiatry 58: 7-12.
11. Benito A, Lerga A, Silva M, Leon J, Fernandez-Luna JL (1997). Apoptosis of human myeloid leukemia cells induced by an inhibitor of protein phosphatases (okadaic acid) is prevented by Bcl-2 and Bcl-X(L). Leukemia 11: 940-944.
12. 4]CyA. Brain Res 988: 56-58.
13. Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B et al (2002). Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 159: 1018-1028.
14. Boe R, Gjertsen BT, Vintermyr OK, Houge G, Lanotte M, Doskeland SO (1991). The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cell. Exp Cell Res 195: 237-246.
15. Cabado AG, Leira F, Vieytes MR, Vieites JM, Botana LM (2004). Cytoskeletal disruption is the key factor that triggers apoptosis in okadaic acid-treated neuroblastoma cells. Arch Toxicol 78: 74-85.
16. Cagnolli CM, Kharlamov E, Atabay C, Uz T, Manev H (1996). Apoptosis induced in neuronal cultures by either the phosphatase inhibitor okadaic acid or the kinase inhibitor staurosporine is attenuated by isoquinolinesulfonamides H-7, H-8 and H-9. J Mol Neurosci 7: 65-76.
17. Casey DE (1997). The relationship of pharmacology to side effects. J Clin Psychiatry 58: s55-s62.
18. Cohen P, Holmes CF, Tsukitani Y (1990). Okadaic acid: a new probe for the study of cellular regulation. Trends Biol Sci 15: 98-102.
19. Cuesta MJ, Peralta V, Zarzuela A (2001). Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophr Res 48: 17-28.
20. DeLisi LE, Sakuma M, Rew W, Kushner M, Hoff AL, Crimson R (1997). Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res 74: 129-140.
21. Fulton B, Goa KL (1997). Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses. Drugs 53: 281-298.
22. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J cell Biol 119: 493-501.
23. Green MF (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153: 321-330.
24. Haldar S, Jena N, Croce CM (1995). Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92: 4507-4511.
25. Harvey PD (1998). Schizophrenia and related disorders in late life. In: Bellack AS, Hersen M (eds). Comprehensive Clinical Psychology. Elsevier: Amsterdam. Vol 8, pp 74-86.
26. Harvey PD, Green MF, McGurk SR, Meltzer HY (2003). Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study. Psychopharmacology 169: 404-411.
27. He J, Xu H, Yang Y, Zhang X, Li XM (2004). Neuroprotective effects of olanzapine on methamphetamine-induced neurotoxicity are associated with an inhibition of hyperthermia and prevention of Bcl-2 decrease in rats. Brain Res 1018: 186-192.
28. He J, Yamada K, Nabeshima T (2002a). A role of Fos expression in the CA3 region of the hippocampus in spatial memory formation in rats. Neuropsychopharmacology 26: 259-268.
29. He J, Yamada K, Zou L, Nabeshima T (2001). Spatial memory deficit and neurodegeneration induced by the direct injection of okadaic acid into the hippocampus in rats. J Neural Transm 108: 1435-1443.
30. He J, Yamada K, Zou L, Nakajima A, Kamei H, Nabeshima T (2002b). Learning and memory in two different reward tasks in a radial arm maze in rats. Behav Brain Res 134: 139-148.
31. Hong HN, Yoon SY, Suh J, Lee JH, Kim D (2002). Differential activation of caspase-3 at two maturational stages during okadaic acid-induced rat neuronal death. Neurosci lett 334: 63-67.
32. Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, Meltzer HY (2002). Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 26: 325-339.
33. Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y et al (1989). Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun 159: 871-877.
34. Kraepelin E (1919). Dementia Praecox and Paraphrenia. E & S Livingstone: Edinburgh.
35. Li X-M, Chlan-Fourney J, Bennett V, Shrikhande S, Juorio AV, Keegan D et al (1999). Differential effects of Olanzapine on the gene expression of superoxide dismutase and low affinity nerve growth factor receptor. J Neurosci Res 56: 72-75.
36. Luo C, Xu H, Li XM (2004). Post-stress changes in BDNF and Bcl-2 immunoreactivities in hippocampal neurons: effect of chronic administration of olanzapine. Brain Res 1025: 194-202.
37. Manna SK, Zhang HJ, Yan T, oberley LW, Aggarwal BB (1998). Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem 273: 13245-13254.
38. Matias WG, Traore A, Bonini M, Sanni A, Creppy EE (1999). Oxygen reactive radicals production in cell culture by okadaic acid and their implication in protein synthesis inhibition. Hum Exp Toxicol 18: 634-639.
39. Mizuno M, Yamada K, Olariu A, Nawa H, Nabeshima T (2000). Involvement of BDNF in spatial memory formation and maintenance in a radial arm maze test in rats. J Neurosci 20: 7116-7121.
40. Nowakowska E, Chodera A, Kus K (1999). Influence of olanzapine on cognitive functions and catalepsy in rats after single and chronic administration. Pol J Pharmacol 51: 295-300.
41. Nuydens R, Dispersyn G, Van Den Keiboom G, de Jong M, Connors R, Ramaekers F et al (2000). Bcl-2 protects against apoptosis-related microtubule alterations in neuronal cells. Apoptosis 5: 43-51.
42. Olton DS, Becker JT, Handelmann GE (1979). Hippocampus, space, and memory. Behav Brain Sci 2: 313-365.
43. Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates. Academic Press: London.
44. Purdon SE, Jones BDW, Stip E, Labelle A, Addington D, David SR et al (2000). Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. Arch Gen Psychiatry 57: 249-258.
45. +-induced apoptosis. Eur J Neurosci 17: 1563-1570.
46. Radecki DT, Brown LM, Martinez J, Teyler TJ (2005). BDNF protects against stress-induced impairments in spatial learning and memory and LTP. Hippocampus 15: 246-253.
47. Ramirez-Munguia N, Vera G, Tapia R (2003). Epilepsy, neurodegeneration, and extracellular glutamate in the hippocampus of awake and anesthetized rats treated with okadaic acid. Neurochem Res 28: 1517-1524.
48. Riordan FA, Foroni L, Hoffbrand AV, Mehta AB, Wickremasinghe RG. (1998). Okadaic acid-induced apoptosis of HL60 leukemia cells is preceded by destabilization of bcl-2 mRNA and down-regulation of bcl-2 protein. FEBS Lett 435: 195-198.
49. Shirazi-Southall S, Rodriguez DE, Nomikos GG (2002). Effects of typical and atypical antipsychotics and receptor selective compounds on acetycholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26: 583-594.
50. Sweatt JD (2004). Hippocampal function in cognition. Psychopharmacology 174: 99-110.
51. Tian Q, Lin Z-Q, Wang X-C, Chen J, Wang Q, Gong C-X et al (2004). Injection of okadaic acid into the meynert nucleus basalis of rat brain induces decreased acetylcholine level and spatial memory deficit. Neuroscience 126: 277-284.
52. Van Dam A-M, Bol JGJM, Binnekade R, Van Muiswinkel FL (1998). Acute or chronic administration of okadaic acid to rats induces brain damage rather than Alzheimer-like neuropathology. Neuroscience 85: 1333-1335.
53. Waddington JL, O'Callaghan E, Buckley P, Larkin C, Redmond O, Stack J et al (1991). The age differences of MRI abnormalities in schizophrenia suggest early ventricular enlargement but later prominence of cortical atrophy. Schizophr Res 5: 188-189.
54. Wang C, Kaufmann JA, Sanchez-Ross MG, Johnson KM (2000). Mechanisms of AT-methyl-D-aspartate-induced apoptosis in phencyclidine-treated cultured forebrain neurons. J Pharmacol Exp Ther 294: 287-295.
55. Wei Z, Bai O, Richardson JS, Mousseau DD, Li X-M (2003a). Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide. J Neurosci Res 73: 364-368.
56. L/s expression and localization. J Neurosci Res 74: 942-947.
57. Wolff MC, Leander JD (2003). Comparison of the effects of antipsychotics on a delayed radial maze task in the rat. Psychopharmacology 168: 410-416.
58. Woods BT, Yurgelun-Todd D, Benes FM, Frankenburg FR, Pope HG, McSparren J (1990). Progressive ventricular enlargement in schizophrenia: comparison to bipolar disorder and correlation with clinical course. Biol Psychiatry 27: 341-352.
59. Zhang X, Cui SS, Wallace AE, Hannesson DK, Schmued LC, Saucier DM et al (2002). Relations between brain pathology and temporal lobe epilepsy. J Neurosci 22: 6052-6061.
60. Zhao WQ, Bennett P, Sedman GL (1995). The impairment of long-term memory formation by the phosphatase inhibitor okadaic acid. Brain Res Bull 36: 557-561.
61. Zou L-B, Yamada K, Tanaka K, Kameyama T, Nabeshima T (1998). Nitric oxide synthase inhibitors impair reference memory formation in a radial arm maze task in rats. Neuropharmacology 37: 323-330.